Letter to "Relationship between maternal mortality and ritodrine hydrochloride as a tocolytic agent in Japan".

The article focuses on the implications of Nakamura et al.'s study, which highlights the risks associated with long-term ritodrine use during perinatal care. Topics include the author's personal reflections on the continued use of ritodrine despite known risks, the belief in Japan's ability to manage adverse effects, and the need to reassess reliance on personal experience versus evidence-based medicine.